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Abstract 
The objective of this study is to investigate the degree of serum sodium changes and its association with patient out‑
comes in pediatrics undergoing heart surgery with cardiopulmonary bypass (CPB). We reviewed the medical records 
of 275 pediatric patients who underwent heart surgery with CPB. Prior to CPB, hyponatremia (≤135 mmol/L) was 
observed in 21 of 275 patients. After initiation of CPB, serum sodium decreased significantly and severe hyponatermia 
(≤130 mmol/L) subsequently developed in 32 patients. At the end of CPB, however, hypernatremia (≥145 mmol/L) 
developed in 86 patients. The degree of acute serum sodium change during CPB was not associated with patient 
outcomes. However, the patients with preoperative hyponatremia and those with hypernatremia at the conclusion 
of CPB had longer hospital stays and higher postoperative complication rates. Lower serum sodium prior to CPB and 
higher serum sodium at the end of CPB, along with age and duration of the operation, were independently associ‑
ated with worse in‑hospital outcomes. Acute and transient hyponatremia occurred frequently after initiation of CPB, 
and then serum sodium immediately increased above preoperative levels at the end of CPB. Caution is required to 
avoid serum sodium overcorrection on the conclusion of CPB.
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Background
Hyponatremia is a common complication prior to ini-
tiating cardiopulmonary bypass (CPB), and is usually 
secondary to underlying heart disease or medications. 
Serum sodium concentration may further change dur-
ing CPB and may be due to a variety of causes, including 
the administration of large fluid volumes (bypass prime 
solutions, cardioplegia, and transfusions) (Darling et  al. 
2000), the use of diuretics, impaired water excretion 
caused by the release of anti-diuretic hormone (Philbin 
et al. 1977), and CPB-related natriuretic effect (Sehested 
et al. 1997).
Sodium disturbances leading to hyponatremia and 
hypernatremia are common problems in hospital-admit-
ted patients and are associated with poor in-hospital 
outcomes (Stelfox et al. 2008; Palevsky et al. 1996; Aram-
patzis et al. 2012). It has been shown that hyponatremia 
is one of the predictive factors of prognosis and length 
of hospital stay of patients with congestive heart failure 
(Mohammed et  al. 2010), neurologic disease (Spaten-
kova et al. 2013), and liver failure (Londono et al. 2006). 
Conversely, abrupt normalization of hyponatremia can 
cause more detrimental effects, leading to morbidities 
such as central pontine myelinolysis (Sterns et al. 1986). 
However, the epidemiology of sodium disturbances dur-
ing CPB has not been well defined, and the implication of 
dysnatremia in patients undergoing cardiac surgery has 
rarely been demonstrated.
When considering the relatively small extracellular 
fluid volume, the risk of acute changes in serum sodium 
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may be increased in pediatric patients. The objective of 
this study is to investigate the degree of changes in serum 
sodium concentration and its relationship with adverse 




A total of 275 pediatric patients (≤15 years of age) who 
underwent surgical repair of ventricular or atrial sep-
tal defects under CPB were identified by retrospective 
review of all CPB cases performed at Samsung Medical 
Center (Seoul, Korea) from July 2005 to June 2010. Dur-
ing the study period, the total number of cardiac sur-
gery cases under CPB from patients of all ages was 3608 
including 1651 surgeries in pediatric patients (≤15 years 
of age). We only included repairs of ventricular or atrial 
septal defects to minimize the effects of confounding fac-
tors (e.g., the type and duration of operation procedure 
or the severity of underlying heart disease) on patient 
outcomes. Patients with a past medical history of chronic 
hypoxemia (room air saturation <90 %), central nervous 
system abnormalities, or chromosomal abnormalities 
were not included.
The study protocol was approved by our institutional 
review board (Samsung Medical Center 2013-04-106-
001). The ethics committee granted a waiver of consent 
for this retrospective chart review study.
Data collection
Demographic, clinical, and hospital data were obtained 
by reviewing patient medical records. All operations 
were performed by two pediatric cardiac surgeons. 
General anesthesia was induced with thiopental and 
midazolam and maintained with isoflurane. Tracheal 
intubation was facilitated with rocuronium. During the 
CPB period, midazolam, fentanyl, and rocuronium were 
infused via CPB circuit to maintain anesthesia. Cardiac 
arrest was induced under CPB and aortic cross clamp 
using crystalloid or blood cardioplegia. Histidine-tryp-
tophan-ketoglutarate (HTK) solution (Custodiol, Als-
bach, Germany) was used as a crystalloid cardioplegia. 
Blood cardioplegia was provided by a mixture of packed 
red blood cells and a commercially available crystalloid 
solution (JW Pharmaceutical, Seoul, Korea) at a ratio 
of 4:1. The initial cardioplegic solution (30  mL/kg) was 
infused at a pressure of 50–60  mmHg. Additional solu-
tion (15  mL/kg) was infused every 20  min in cases of 
blood cardioplegia. Hemodynamic monitoring included 
electrocardiography, pulse oximetry, esophageal-rectal 
temperature, invasive radial artery pressure monitoring, 
and central venous pressure. Arterial blood gas and elec-
trolytes were measured at baseline, during the rewarming 
period, and every 30 min thereafter. Modified ultrafiltra-
tion was performed after CPB weaning.
Pediatric Risk of Mortality (PRISM III) scores were 
calculated with age-related physiological parameters 
including systolic blood pressure, heart rate, tempera-
ture, pupillary reflexes, mental status, acidosis (pH and 
total CO2), pCO2, pO2, glucose, potassium, creatinine, 
blood urea, white blood cell counts, platelet counts, and 
prothrombin or partial thromboplastin times (Pollack 
et al. 1988). This scoring system has a range of 0–74, and 
a higher score indicates a higher mortality risk.
We determined in-hospital outcome variables by 
review of medical records. The postoperative morbid-
ity rates, such as neurologic complications, arrhythmia, 
pulmonary congestion, pneumonia, jaundice, or acute 
kidney injury were determined. We attempted to iden-
tify neurologic complications including seizures, coma, 
cerebral edema, or cerebral lesions documented on 
imaging studies included in the medical records. Acute 
kidney injury was defined as a ≥50 % increase in serum 
creatinine or an absolute increase in serum creatinine of 
≥0.3 mg/dL. We also determined the lengths of postop-
erative hospital stay (intensive care unit and total hospital 
days) as an additional outcome variable.
Statistical analysis
All statistical analyses were performed with the SPSS 
software package (version 19.0; SPSS Inc, Chicago, IL). 
Continuous clinical variables are presented as means 
and SDs or as medians and ranges. The patients were 
classified by the following clinical definitions: hypona-
tremia prior to CPB (serum sodium ≤135  mmol/L), 
severe hyponatremia during CPB, (serum sodium 
≤130  mmol/L), and hypernatremia after CPB (serum 
sodium ≥145  mmol/L). Comparisons between two 
groups were conducted using an unpaired t-test or the 
Mann–Whitney U-test, as appropriate. Distributions of 
categorical variables among groups were assessed using a 
Chi-square test. Generalized linear models were used to 
find independent prognostic factors. Two-sided p-values 
<0.05 were considered statistically significant.
Results
The median patient age (145 male and 130 female) was 
14 months (range 1–180 months) and the median PRISM 
score was 2 (range 0–10) (Table  1). The mean duration 
of operation and CPB were 203 ± 36 and 69 ± 22 min, 
respectively (Table 2).
Changes in serum sodium concentrations during CPB 
are shown in Fig. 1. Prior to heart surgery, hyponatremia 
(≤135 mmol/L) was observed in 21 of 275 patients. After 
initiation of CPB, serum sodium decreased significantly 
(P  <  0.001) and severe hyponatermia (≤130  mmol/L) 
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developed in 32 patients. At the end of CPB, however, 
serum sodium concentrations immediately increased 
(P < 0.001) above preoperative levels and hypernatremia 
(≥145  mmol/L) rather than hyponatremia developed in 
86 patients.
Postoperative complications developed in 70 of the 275 
patients. Among those with complications, 25 patients 
suffered two or more complications. Acute kidney injury 
was the most common complication and occurred in 38 
patients. Pulmonary congestion and pneumonia devel-
oped in 19 and 21 patients, respectively. Additionally, 
arrhythmias developed in 8 patients and liver dysfunc-
tion developed in 5 patients. Neurologic complications 
were rare and transient ankle jitteriness or headache 
developed in 3 patients.
Associations between serum sodium concentrations 
and in-hospital outcomes are shown in Table  3. The 
patients with preoperative hyponatremia had longer hos-
pital stays (intensive care unit and total hospital days) 
and higher postoperative complication rates. However, 
the degree of acute serum sodium changes during CPB 
was not associated with poor patient outcomes. On the 
other hand, increased serum sodium concentrations at 
the end of CPB were associated with longer hospital stays 
and higher morbidity rates.
Independent prognostic factors for patient outcomes 
were assessed using generalized linear models (Table 4). 
Lower serum sodium concentrations prior to and higher 
serum sodium concentrations after CPB, along with 
younger age and longer operation times, were indepen-
dently associated with poor in-hospital outcomes.
Discussion
In this observational study, serum sodium concentrations 
substantially decreased after initaiation of CPB, and then 
immediately increased above preoperative levels at the 
completion of CPB. Acute and transient hyponatremia 
during CPB was not associated with patient outcomes. 
However, preoperative hyponatremia and overcorrection 
of serum sodium at the end of CBP were associated with 
Table 1 Baseline patient characteristics (n = 275)
PRISM pediatric risk of mortality
Age, months [median (range)] 14 (1–180)
Male/female, n (%) 145/130 (52.7/47.3 %)
Weight, kg [median (range)] 9.6 (2.4–83)
Body surface area, m2 [median (range)] 0.46 (0.18–2.03)
PRISM score [median (range)] 2 (0–10)
Serum creatinine, mg/dL (mean ± SD) 0.38 ± 0.14
Table 2 Cardio-pulmonary bypass procedure
CPB cardiopulmonary bypass
Operation duration, min (mean ± SD) 203 ± 36
CPB duration, min (mean ± SD) 69 ± 22
Priming volume, mL (mean ± SD) 124 ± 65
Serum sodium, mmol/L (mean ± SD)
 Prior to CPB 139.3 ± 3.0
 Lowest during CPB 135.7 ± 4.3
 After the end of CPB 142.7 ± 4.0
Serum glucose, mg/dL (mean ± SD) 157 ± 44
Nasopharyngeal temp, ºC (mean ± SD) 31.0 ± 1.8
Fig. 1 Acute serum sodium concentration changes during cardio‑
pulmonary bypass (error bar; mean concentration with 95 % CI)
Table 3 Serum sodium concentrations and postoperative outcomes
CPB cardiopulmonary bypass, ICU intensive care unit
Outcomes Prior to CPB (mmol/L) Lowest during CPB (mmol/L) After CPB (mmol/L)
≤135 >135 P ≤130 >130 P ≤145 >145 P
ICU morbidity, events [n (%)] 12/21 (57 %) 58/254 (23 %) 0.001 4/32 (13 %) 66/243 (27 %) 0.074 31/189 (16 %) 39/86 (45 %) <0.001
Length of ICU stay, days [median 
(range)]
5 (3–10) 2 (1–13) <0.001 2 (2–9) 2 (1–13) 0.057 2 (1–10) 3.5 (2–13) <0.001
Length of hospital stay, days [median 
(range)]
9 (7–22) 7 (5–21) <0.001 7 (5–13) 7 (5–22) 0.900 7 (5–19) 8.5 (6–22) <0.001
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longer hospital admission lengths and higher morbidity 
rates.
The clinical implication of sodium disturbances during 
CPB has not been well documented. In this study, serum 
sodium concentrations significantly decreased, and 
severe hyponatremia, defined as a serum sodium con-
centration less than 130 mEq/L, was frequently observed 
during CPB. Possible mechanisms for hyponatremia are 
likely multifactorial, but include etiologies such as fluid 
overload (prime solutions, cardioplegia, and transfusions) 
(Darling et  al. 2000), diuretic administration, impaired 
water excretion caused by the release of anti-diuretic hor-
mone (Philbin et  al. 1977), and CPB-related natriuretic 
effect (Sehested et al. 1997). Theoretically, hyponatremia 
during CPB may contribute to cerebral edema or related 
complications if associated with a decrease in serum 
osmolality. However, we did not have sufficient data on 
temporal osmolality changes during CPB in this study, 
and the degree of acute serum sodium decrease during 
CPB was not associated with patient outcomes. A recent 
study conducted in cardiac surgery patients showed that 
acute hyponatremia during cardioplegia with HTK solu-
tion was isotonic and that the measured osmolality did 
not change during surgery (Lindner et al. 2012). If acute 
decreases in serum sodium during CPB was due to pseu-
dohyponatremia with a normal plasma tonicity, then 
harmful effects would not likely result.
In previous studies regarding baseline serum sodium 
concentrations, hyponatremia has been established as a 
poor prognostic factor and may predict poor outcomes 
or longer hospital stay in patients with congestive heart 
failure (Mohammed et al. 2010). Hyponatremia was also 
an independent risk factor of poor outcomes in critically 
ill patients admitted to the ICU (Stelfox et al. 2008). Heart 
surgery patients may be critically ill and have comor-
bidities such as heart failure. A number of clinical and 
surgical factors have been identified as predictors of poor 
outcomes after heart surgery, including heart failure, kid-
ney injury, comorbidities, and prolonged or complicated 
surgical procedures. Hyponatremia is commonly asso-
ciated with those factors, and a recent study has shown 
that baseline hyponatremia is an independent risk factor 
for adverse events, prolonged hospital stay, and mortal-
ity after heart surgery (Lindner et al. 2012). Our results 
may also provide additional information regarding the 
relationships between preoperative hyponatremia and in-
hospital outcomes in pediatric patients undergoing heart 
surgery with CPB.
At the conclusion of CPB, hypernatremia 
(≥145 mmol/L) was observed in approximately one-third 
of patients and was associated with longer hospital stays 
and higher morbidity rates. The prevalence of postopera-
tive hypernatremia in patients after cardiac surgery has 
rarely been demonstrated, and the impact on clinical out-
comes has been unclear. Hypernatremia has only recently 
been shown to be a common event in intensive care units 
after major cardiothoracic surgery, and was associated 
with an increased risk of hospital mortality (Lindner et al. 
2010). However, the cause of hypernatremia after car-
diac surgery is not clear. On the review of medical and 
surgical records in this study, there were no administra-
tions of hypertonic saline by the anesthesiologist; how-
ever, sodium bicarbonate was frequently administered 
during CPB to correct for metabolic acidosis or acute 
hyponatremia. Unlike hyponatremia, which would be 
iso- or even hyperosmotic, hypernatremia is consistently 
associated with hyperosmolality. The overcorrection 
of hyponatremia, which might have been iso-osmotic 
during CPB (Lindner et  al. 2012) or partially compen-
sated for by adaptation mechanisms (Verbalis and Gul-
lans 1991; Gullans and Verbalis 1993), may result in cell 
shrinkage, which might cause various complications and 
Table 4 Generalized linear models predicting postoperative outcomes
CPB cardiopulmonary bypass, ICU intensive care unit
a Log-transformed values were used for the analyses
Co-variables ICU morbidity Length of ICU stay (day)a
Coefficient (B) Standard error of B P Coefficient (B) Standard error of B P
Age (months) −2.548 0.4285 <0.001 −0.213 0.0199 <0.001
Gender (male) 0.393 0.3867 0.310 0.004 0.0193 0.844
PRISM III (score) −0.178 0.1021 0.080 0.002 0.0050 0.660
Operation duration (min) 0.019 0.0060 0.001 0.001 0.0003 <0.001
Serum sodium (mmol/L)
 Prior to CPB −0.206 0.0808 0.011 −0.010 0.0039 0.013
 Lowest during CPB −0.010 0.0558 0.857 −0.001 0.0028 0.622
 After the end of CPB 0.133 0.0614 0.031 0.007 0.0031 0.019
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poor outcomes. For example, cerebral shrinkage can lead 
to neurologic impairment. Moreover, a decrease in car-
diac contractility (Lenz et  al. 1986; Kozeny et  al. 1985) 
and disturbances in glucose metabolism (Bratusch-Mar-
rain and DeFronzo 1983) and immunologic functions 
(Kuroda et  al. 1997) have been described in association 
with hypernatremic hyperosmolar states. Thus, overcor-
rection of hyponatremia should be viewed as an emer-
gent problem and avoided in patients undergoing CPB.
This study has several limitations. First, data on osmo-
lality was not available, and thus we could not distinguish 
between hypoosmolar, isoosmolar, and hyperosmolar 
hyponatremia. Second, our study was retrospective and 
observational in nature. As such, our observations are 
valuable for generating hypotheses but not causal infer-
ence. Third, the sample size was small, resulting in lim-
ited power to detect associations by statistical analyses. 
Specifically, all possible confounders could not be con-
currently introduced in the multivariable analysis. Forth, 
this study included patients undergoing repair of ventric-
ular or atrial septal defects at a single center (to minimize 
the effects of confounding factors on patient outcomes), 
which makes drawing generalized conclusions more dif-
ficult. It is possible that patients undergoing other types 
of cardiac surgery or other patient populations may have 
different experiences.
In conclusion, serum sodium concentrations substan-
tially decreased after initaiation of CPB, and then imme-
diately increased above preoperative levels at the end of 
CPB. Acute and transient hyponatremia during CPB was 
not related to patient outcomes. However, overcorrection 
of serum sodium at the conclusion of CPB was associated 
with poor in-hospital outcomes. These results suggest 
that acute hyponatremia during CPB does not warrant 
immediate treatment by raising serum sodium levels, and 
caution is required to avoid serum sodium overcorrec-
tion on the conclusion of CPB.
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